Josep Maria Haro

Summary

Country: Spain

Publications

  1. doi Antipsychotic treatment discontinuation in previously untreated patients with schizophrenia: 36-month results from the SOHO study
    Josep Maria Haro
    Sant Joan de Deu SSM, Fundació Sant Joan de Déu, CIBER Salud Mental Instituto de Salud Carlos III, Sant Boi de Llobregat, Barcelona, Spain
    J Psychiatr Res 43:265-73. 2009
  2. ncbi Evidence for three distinct classes of 'typical', 'psychotic' and 'dual' mania: results from the EMBLEM study
    J M Haro
    Sant Joan de Deu SSM, Fundació Sant Joan de Déu, St Boi de Llobregat, Barcelona, Spain
    Acta Psychiatr Scand 113:112-20. 2006
  3. ncbi Treatment-seeking behavior of erectile dysfunction patients in Europe: Results of the Erectile Dysfunction Observational Study
    Josep Maria Haro
    Fundació Sant Joan de Déu, Esplugues de Llobregat, Spain
    J Sex Med 3:530-40. 2006
  4. ncbi Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study
    Josep Maria Haro
    Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
    J Clin Psychopharmacol 26:571-8. 2006
  5. ncbi Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: observational versus randomized studies results
    Josep Maria Haro
    San Joan de Déu Serveis de Salut Mental, Fundació Sant Joan de Déu, Dr Antoni Pujades, 42, 08830 Sant Boi de Llobregat, Barcelona, Spain
    Eur Neuropsychopharmacol 17:235-44. 2007
  6. ncbi Predictors of the course of illness in outpatients with schizophrenia: a prospective three year study
    J M Haro
    Sant Joan de Deu SSM, Fundació Sant Joan de Déu, CIBER SAM, Spain
    Prog Neuropsychopharmacol Biol Psychiatry 32:1287-92. 2008
  7. doi 2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery
    J M Haro
    Parc Sanitari Sant Joan De Deu SSM, Centro de Investigación Biomédica en Red en Salud Mental CIBERSAM, Sant Boi de Llobregat, Barcelona, Spain
    Eur Neuropsychopharmacol 21:287-93. 2011
  8. ncbi [Remission and relapse in the outpatient treatment of patients with schizophrenia. Outcomes at 3 years]
    J M Haro
    Fundacion San Juan de Dios, Barcelona, Spain
    Actas Esp Psiquiatr 36:187-96. 2008
  9. doi Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM)
    Eduard Vieta
    Department of Psychiatry, Hospital Clinic, University of Barcelona IDIBAPS, CIBER SAM, Barcelona, Spain
    J Affect Disord 118:118-23. 2009
  10. doi Impact of mental disorders and chronic physical conditions in health-related quality of life among primary care patients: results from an epidemiological study
    Alejandra Pinto-Meza
    Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Barcelona, Spain
    Qual Life Res 18:1011-8. 2009

Detail Information

Publications96

  1. doi Antipsychotic treatment discontinuation in previously untreated patients with schizophrenia: 36-month results from the SOHO study
    Josep Maria Haro
    Sant Joan de Deu SSM, Fundació Sant Joan de Déu, CIBER Salud Mental Instituto de Salud Carlos III, Sant Boi de Llobregat, Barcelona, Spain
    J Psychiatr Res 43:265-73. 2009
    ..In conclusion, treatment effectiveness and tolerability varied among antipsychotic medications in previously untreated patients with schizophrenia. The results should be interpreted conservatively given the observational study design...
  2. ncbi Evidence for three distinct classes of 'typical', 'psychotic' and 'dual' mania: results from the EMBLEM study
    J M Haro
    Sant Joan de Deu SSM, Fundació Sant Joan de Déu, St Boi de Llobregat, Barcelona, Spain
    Acta Psychiatr Scand 113:112-20. 2006
    ..To describe patients included in the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) study and to assess and clinically validate the presence of clinical subtypes of patients with acute mania...
  3. ncbi Treatment-seeking behavior of erectile dysfunction patients in Europe: Results of the Erectile Dysfunction Observational Study
    Josep Maria Haro
    Fundació Sant Joan de Déu, Esplugues de Llobregat, Spain
    J Sex Med 3:530-40. 2006
    ....
  4. ncbi Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study
    Josep Maria Haro
    Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
    J Clin Psychopharmacol 26:571-8. 2006
    ..The results should be interpreted conservatively because of the observational, nonrandomized study design...
  5. ncbi Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: observational versus randomized studies results
    Josep Maria Haro
    San Joan de Déu Serveis de Salut Mental, Fundació Sant Joan de Déu, Dr Antoni Pujades, 42, 08830 Sant Boi de Llobregat, Barcelona, Spain
    Eur Neuropsychopharmacol 17:235-44. 2007
    ..Antipsychotic maintenance in SOHO was higher than the results of previous randomized studies...
  6. ncbi Predictors of the course of illness in outpatients with schizophrenia: a prospective three year study
    J M Haro
    Sant Joan de Deu SSM, Fundació Sant Joan de Déu, CIBER SAM, Spain
    Prog Neuropsychopharmacol Biol Psychiatry 32:1287-92. 2008
    ..The results show that description of the long-term outcome of schizophrenia cannot be summarized with just one outcome variable...
  7. doi 2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery
    J M Haro
    Parc Sanitari Sant Joan De Deu SSM, Centro de Investigación Biomédica en Red en Salud Mental CIBERSAM, Sant Boi de Llobregat, Barcelona, Spain
    Eur Neuropsychopharmacol 21:287-93. 2011
    ..In conclusion, functional recovery occurred in approximately half of those who achieved remission. Impairment of work and social functioning was consistently associated with lower remission and recovery rates...
  8. ncbi [Remission and relapse in the outpatient treatment of patients with schizophrenia. Outcomes at 3 years]
    J M Haro
    Fundacion San Juan de Dios, Barcelona, Spain
    Actas Esp Psiquiatr 36:187-96. 2008
    ..Three year data collected in the frame of the SOHO study within Spain were used to evaluate antipsychotic treatment outcomes by analyzing remission and relapse as well as the factors influencing them...
  9. doi Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM)
    Eduard Vieta
    Department of Psychiatry, Hospital Clinic, University of Barcelona IDIBAPS, CIBER SAM, Barcelona, Spain
    J Affect Disord 118:118-23. 2009
    ..Large observational studies may be useful in identifying variables that predict switch to depression after mania and provide data on medication use and outcomes in "real world" patients...
  10. doi Impact of mental disorders and chronic physical conditions in health-related quality of life among primary care patients: results from an epidemiological study
    Alejandra Pinto-Meza
    Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Barcelona, Spain
    Qual Life Res 18:1011-8. 2009
    ..To estimate the comorbidity of mental disorders with chronic physical conditions and to assess their independent and combined effects on health-related quality of life (HRQOL)...
  11. doi Cognitive correlates of verbal memory and verbal fluency in schizophrenia, and differential effects of various clinical symptoms between male and female patients
    Gildas Brébion
    Unitat de Recerca, Parc Sanitari Sant Joan de Deu, Barcelona, Spain CIBERSAM, Spain
    Schizophr Res 147:81-5. 2013
    ..Various clinical symptoms might affect cognitive efficiency as well. Notably, previous research has revealed the role of affective symptoms on memory performance in this population, and suggested sex-specific effects...
  12. doi Analysis of Sp transcription factors in the postmortem brain of chronic schizophrenia: a pilot study of relationship to negative symptoms
    Raquel Pinacho
    Unitat de Recerca, Parc Sanitari Sant Joan de Deu, Fundació Sant Joan de Déu, Universitat de Barcelona, Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Dr Antoni Pujadas, 42, 08830 Sant Boi de Llobregat, Barcelona, Spain
    J Psychiatr Res 47:926-34. 2013
    ....
  13. doi Factors predicting hostility in outpatients with schizophrenia: 36-month results from the SOHO study
    Susana Ochoa
    Research Unit, Parc Sanitari Sant Joan de Deu, CIBERSAM, Barcelona, Spain
    J Nerv Ment Dis 201:464-70. 2013
    ..Extrapyramidal symptoms and tardive dyskinesia, alcohol/substance abuse, cognitive impairment, medication noncompliance, and hospitalizations are predictors of future hostility...
  14. ncbi Adjustment disorders in primary care: prevalence, recognition and use of services
    Anna Fernandez
    Parc Sanitari Sant Joan de Deu, Research and Development Unit, Fundació Sant Joan de Déu, Dr Antoni Pujadas 42, Sant Boi de Llobregat, Barcelona, Spain
    Br J Psychiatry 201:137-42. 2012
    ..Within the ICD and DSM review processes there is growing debate on the future classification and status of adjustment disorders, even though evidence on this clinical entity is scant, particularly outside specialised care...
  15. doi Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) study
    Josep Maria Haro
    Parc Sanitari Sant Joan de Deu, Fundació Sant Joan de Déu, CIBERSAM, Dr Antoni Pujadas, 42, 08830 Sant Boi de Llobregat, Barcelona, Spain
    Br J Psychiatry 199:194-201. 2011
    ..Evidence suggests that schizophrenia may have a better outcome for individuals living in low- and middle-income countries compared with affluent settings...
  16. ncbi Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study
    Eduard Vieta
    Bipolar Disorders Program, Hospital Clinic, University of Barcelona IDIBAPS, Barcelona, Spain
    J Affect Disord 106:63-72. 2008
    ....
  17. ncbi Gender differences in response to antipsychotic treatment in outpatients with schizophrenia
    Judith Usall
    Sant Joan de Déu Serveis de Salut Mental, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
    Psychiatry Res 153:225-31. 2007
    ..In conclusion, in this group of outpatients with schizophrenia, gender is a predictor of clinical response to antipsychotic treatment, but its influence is not the same for all antipsychotics...
  18. ncbi What is the relative importance of self reported psychotic symptoms in epidemiological studies? Results from the ESEMeD--Catalonia Study
    Susana Ochoa
    Sant Joan de Déu Serveis de Salut Mental, Fundació Sant Joan de Déu, Dr Pujades, 42, Sant Boi de Llobregat, Barcelona, CIBERSAM Spain
    Schizophr Res 102:261-9. 2008
    ....
  19. doi Effectiveness of olanzapine monotherapy and olanzapine combination treatment in the long term following acute mania--results of a two year observational study in bipolar disorder (EMBLEM)
    Ana Gonzalez-Pinto
    International Mood Disorders Research Centre, Centro de Investigación Biomédica en Red en Salud Mental CIBERSAM, Hospital Santiago Apostol, University of the Basque Country, Vitoria, Spain
    J Affect Disord 131:320-9. 2011
    ..This study compared the 2-year outcomes of patients with a manic/mixed episode of bipolar disorder taking olanzapine monotherapy or olanzapine in combination with other agents...
  20. ncbi Reduced expression of SP1 and SP4 transcription factors in peripheral blood mononuclear cells in first-episode psychosis
    Montserrat Fusté
    Unitat de Recerca, Parc Sanitari Sant Joan de Deu, Fundació Sant Joan de Déu, Universitat de Barcelona, Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Dr Antoni Pujadas, 42, 08830 Sant Boi de Llobregat, Barcelona, Spain
    J Psychiatr Res 47:1608-14. 2013
    ..Our study shows reduced SP1 and SP4 protein levels in first-episode psychosis in lymphocytes, suggesting that these transcription factors are potential peripheral biomarkers of psychotic spectrum disorders in the early stages...
  21. doi Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study
    Adriane R Rosa
    Bipolar Disorders Program, Hospital Clinic, University of Barcelona, CIBERSAM, Barcelona, Spain
    J Clin Psychiatry 71:1000-6. 2010
    ..Antidepressants are supposed to be withdrawn during a manic episode. The aim of this study was to analyze the characteristics of manic patients who received antidepressants during a manic phase in a large, naturalistic study...
  22. doi Suicide ideation across reproductive life cycle of women. Results from a European epidemiological study
    Judith Usall
    Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Instituto de Salud Carlos III, Centro de Investigación en Red de Salud Mental CIBERSAM, Spain
    J Affect Disord 116:144-7. 2009
    ..The aim of the present study is to compare suicide ideation among women in the pre-, peri-, and post-menopause using a cross-sectional household survey of non-institutionalised adults from six European countries...
  23. doi Adequacy of antidepressant treatment in Spanish primary care: a naturalistic six-month follow-up study
    Alejandra Pinto-Meza
    Department of Research and Development, Sant Joan de Deu SSM, Carrer Dr Antoni Pujades, 42 Sant Boi de Llobregat, Barcelona, Spain
    Psychiatr Serv 59:78-83. 2008
    ..Factors that could be associated with adequacy of care also were explored...
  24. doi Burden of chronic physical conditions and mental disorders in primary care
    Anna Fernandez
    Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Research and Development Unit, Dr Antoni Pujadas, 42, 08830 Sant Boi de Llobregat, Barcelona, Spain
    Br J Psychiatry 196:302-9. 2010
    ..The World Health Organization (WHO) has stated that the three leading causes of burden of disease in 2030 are projected to include HIV/AIDS, unipolar depression and ischaemic heart disease...
  25. doi Three-factor model of premorbid adjustment in a sample with chronic schizophrenia and first-episode psychosis
    Ana Barajas
    Department of Research, Centre d Higiene Mental Les Corts, Barcelona, Spain Parc Sanitari Sant Joan de Déu, Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Sant Boi de Llobregat, Barcelona, Spain Hospital Sant Joan de Déu de Barcelona, Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Esplugues de Llobregat, Barcelona, Spain Fundació Sant Joan de Déu de Barcelona, Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Esplugues de Llobregat, Barcelona, Spain Departament de Psicologia Clínica i de la Salut, Facultat de Psicologia, Universitat Autonoma de Barcelona, Bellaterra, Cerdanyola del Valles, Spain Electronic address
    Schizophr Res 151:252-8. 2013
    ....
  26. doi Social inequalities in mental health: results from the EU contribution to the World Mental Health Surveys Initiative
    Alejandra Pinto-Meza
    Parc Sanitari Sant Joan de Deu, C Dr Antoni Pujadas, 42, Sant Boi de Llobregat, 08830 Barcelona, Spain
    Soc Psychiatry Psychiatr Epidemiol 48:173-81. 2013
    ..The objective of the present study was to provide updated data from nine European countries about the impact of social inequalities in the prevalence of common mental disorders...
  27. doi REPYFLEC cognitive remediation group training in schizophrenia: Looking for an integrative approach
    Aida Farreny
    Parc Sanitari Sant Joan de Deu, Fundació Sant Joan de Déu, Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Sant Boi de Llobregat, Barcelona, Spain
    Schizophr Res 142:137-44. 2012
    ..However, results are not the same in all CR therapies and in some cases no efficacy results are achieved...
  28. doi Gender differences in outcomes of acute mania: a 12-month follow-up study
    Laia Miquel
    Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Centro de Investigación Biomédica en Red de Salud Mental, Catalonia, Spain
    Arch Womens Ment Health 14:107-13. 2011
    ..Women had a faster time to mania improvement and a higher risk of developing a depressive episode during the 12-month follow-up period...
  29. pmc Disability mediates the impact of common conditions on perceived health
    Jordi Alonso
    IMIM Institut Hospital del Mar d Investigacions Mèdiques, Barcelona, Spain Pompeu Fabra University, Barcelona, Spain
    PLoS ONE 8:e65858. 2013
    ..We examined the extent to which disability mediates the observed associations of common mental and physical conditions with perceived health...
  30. doi Recognition of anxiety disorders by the general practitioner: results from the DASMAP study
    Anna Fernandez
    Research and Development Unit, Parc Sanitari Sant Joan de Deu, Fundació Sant Joan de Déu, Barcelona, Spain
    Gen Hosp Psychiatry 34:227-33. 2012
    ..The objectives were to determine the levels of general practitioner (GP) recognition of anxiety disorders and examine associated factors...
  31. doi Obsessive-compulsive symptom dimensions in the general population: results from an epidemiological study in six European countries
    M A Fullana
    Anxiety Unit, IAPS, Hospital del Mar and Department of Psychiatry, Autonomous University of Barcelona, Barcelona, Spain
    J Affect Disord 124:291-9. 2010
    ..The prevalence of obsessive-compulsive symptom dimensions and their sociodemographic and psychopathological correlates at the population level are unknown...
  32. doi Development of the insight scale for affective disorders (ISAD): modification from the scale to assess unawareness of mental disorder
    Beatriz Olaya
    Parc Sanitari Sant Joan de Deu, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
    J Affect Disord 142:65-71. 2012
    ..The aim of the present study is to develop a short, multidimensional, reliable and valid scale to measure insight in patients with mood disorders, based on the Amador's Scale to Assess Unawareness of Mental Disorders (SUMD)...
  33. ncbi Four symptom dimensions in outpatients with schizophrenia
    Victoria Villalta-Gil
    Research and Development Unit, Sant Joan de Deu, Serveis de Salut Mental, Fundació Sant Joan de Déu, St Boi de Llobregat, Spain
    Compr Psychiatry 47:384-8. 2006
    ..The aim of this study was to assess the dimensional structure of the Positive and Negative Symptoms Scale (PANSS) to identify the psychopathological profiles of outpatients with schizophrenia...
  34. doi Psychotropic prescribing in Catalonia: results from an epidemiological study
    Maria Rubio-Valera
    Research and Development Unit, Parc Sanitari Sant Joan de Deu, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
    Fam Pract 29:154-62. 2012
    ..Mental disorders (MDs) are mainly treated in primary care (PC), where psychotropic drug (PSD) prescribing is highly prevalent. Prescription of PSD is associated with clinical and non-clinical factors...
  35. ncbi [Prevalence and physical-mental comorbidity of chronic back and neck pain in Spain: results from the ESEMeD Study]
    Alejandra Pinto-Meza
    Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Espana
    Med Clin (Barc) 127:325-30. 2006
    ..The objectives of following study, that is part of the ESEMeD-Spain study, are to estimate CBP-CNP prevalence among Spanish population, its comorbidity with other physical and mental conditions, and its impact on global functioning...
  36. doi Do needs, symptoms or disability of outpatients with schizophrenia influence family burden?
    Susana Ochoa
    Unitat de Recerca i Desenvolupament de Sant Joan de Déu SSM Research Unit CIBER SAM, C Pujades, 42, 08330, Sant Boi de Llobregat, Barcelona, Spain
    Soc Psychiatry Psychiatr Epidemiol 43:612-8. 2008
    ..This could cause high levels of family burden. The objective of this study is to assess the relationship between the patients' needs and other clinical and disability variables and the level of family burden...
  37. ncbi Factors associated with active aging in Finland, Poland, and Spain
    Jaime Perales
    Parc Sanitari Sant Joan de Deu, Sant Boi de Llobregat, Barcelona, Spain
    Int Psychogeriatr 26:1363-75. 2014
    ..Actions to promote AA in these countries may be addressed at reducing inequalities in occupation and education or directly tackling the components of AA lacking in each country. ..
  38. doi Spanish validation of the Premorbid Adjustment Scale (PAS-S)
    Ana Barajas
    Department of Research, Centre d Higiene Mental Les Corts, Barcelona, Spain
    Compr Psychiatry 54:187-94. 2013
    ..The Premorbid Adjustment Scale (PAS) has been the most widely used scale to quantify premorbid status in schizophrenia, coming to be regarded as the gold standard of retrospective assessment instruments...
  39. doi Abnormal functioning of the semantic network in schizophrenia patients with thought disorganization. An exemplar production task
    Gildas Brébion
    Unit of Research and Development, Parc Sanitari Sant Joan de Déu and CIBERSAM, Barcelona, Spain
    Psychiatry Res 205:1-6. 2013
    ..This effect is counteracted by affective flattening...
  40. doi Marginal structural models might overcome confounding when analyzing multiple treatment effects in observational studies
    David Suarez
    Research and Development Unit, Sant Joan de Deu SSM, Fundació Sant Joan de Déu, RETICS RD06 0011 REM TAP Network, Sant Boi, Barcelona, Spain
    J Clin Epidemiol 61:525-30. 2008
    ..Until now, MSMs have not been used to compare the effects of more than two treatments...
  41. doi Rapid-cycling bipolar I disorder: course and treatment outcome of a large sample across Europe
    N Cruz
    Bipolar Disorders Program, Hospital Clinic, University of Barcelona, IDIBAPS, CIBER SAM, Barcelona, Spain
    J Psychiatr Res 42:1068-75. 2008
    ..To evaluate the baseline characteristics and follow-up outcomes of rapid-cycling (RC) bipolar I patients in a large, prospective, observational study...
  42. doi Functional similarity of facial emotion processing between people with a first episode of psychosis and healthy subjects
    Victoria Villalta-Gil
    Parc Sanitari Sant Joan de Deu, Fundació Sant Joan de Déu, Centro de Investigación Biomédica en Red CIBERSAM, Sant Boi de Llobregat, Barcelona, Spain
    Schizophr Res 149:35-41. 2013
    ..The present work focuses on assessing FEmoP in people experiencing a psychotic episode for the first time with different experimental paradigm approaches...
  43. ncbi Treatment adequacy of anxiety and depressive disorders: primary versus specialised care in Spain
    Anna Fernandez
    Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
    J Affect Disord 96:9-20. 2006
    ..This study aimed to describe the adequacy of treatment for Anxiety and Depressive disorders in Spain, how this differs between providers (primary versus specialised care) and which factors are associated with appropriate care...
  44. doi Health-related quality-of-life instruments for Alzheimer's disease and mixed dementia
    Jaime Perales
    Parc Sanitari Sant Joan de Deu, Universitat de Barcelona, Sant Boi de Llobregat, Barcelona, Spain
    Int Psychogeriatr 25:691-706. 2013
    ..The aim of this review is to synthesize evidence from published reviews on HRQL measures in dementia and any new literature in order to identify dementia specific HRQL instruments, the domains they measure, and their operationalization...
  45. doi Adaptation and validation of the quality-of-life scale: Satisfaction with Life Domains Scale by Baker and Intagliata
    Janina Carlson
    Research and Developmental Unit of Sant Joan de Déu SSM, Fundació Sant Joan de Déu, 08330 Sant Boi de Llobregat, Barcelona, Spain
    Compr Psychiatry 50:76-80. 2009
    ..There are few quality-of-life instruments specifically for schizophrenia; thus, the objective of our study is to adapt and validate the Satisfaction with Life Domains Scale (SLDS) by Baker and Intagliata...
  46. ncbi Antipsychotic type and correlates of antipsychotic treatment discontinuation in the outpatient treatment of schizophrenia
    Josep Maria Haro
    Research and Development Unit, Sant Joan de Déu Serveis de Salut Mental, Dr Antoni Pujades 42, 08030 Sant Boi, Barcelona, Spain
    Eur Psychiatry 21:41-7. 2006
    ..The findings from this study should be interpreted conservatively because of its non-randomized observational design...
  47. doi Overview of the findings from the European SOHO study
    David Suarez
    Sant Joan de Déu Serveis de Salut Mental, Fundació Sant Joan de Déu, Barcelona, Spain
    Expert Rev Neurother 8:873-80. 2008
    ..The results from the SOHO study indicate that differences in effectiveness and tolerability do exist between the antipsychotics...
  48. ncbi Fluoxetine and imipramine: are there differences in cost-utility for depression in primary care?
    Antoni Serrano-Blanco
    Sant Joan de Déu Serveis de Salut Mental, Fundació Sant Joan de Déu, Sant Boi de Ll, Barcelona, Spain
    J Eval Clin Pract 15:195-203. 2009
    ..Previous cost-utility studies, comparing selective serotonin reuptake inhibitors and tricyclic antidepressants, have used modelling techniques or have not included indirect costs in the economic analyses...
  49. ncbi Methodological aspects in the assessment of treatment effects in observational health outcomes studies
    Josep Maria Haro
    Research and Development Unit, RIRAG Network FIS G03 061, Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Sant Boi, Barcelona, Spain
    Appl Health Econ Health Policy 5:11-25. 2006
    ..Observational studies, when properly conducted and when using adequate statistical methods, can provide valid information on the evaluation of health technologies...
  50. doi Reasons and outcomes of olanzapine dose adjustments in the outpatient treatment of schizophrenia
    D Suarez
    Sant Joan de Deu SSM, Fundació Sant Joan de Déu, CIBER Salud Mental Instituto de Salud Carlos III, Sant Boi de Llobregat, Barcelona, Spain
    Pharmacopsychiatry 42:135-40. 2009
    ..Antipsychotic treatment dose adjustments may influence treatment outcomes in patients with schizophrenia...
  51. doi Multimorbidity patterns in a national representative sample of the Spanish adult population
    Noe Garin
    Research Unit, Parc Sanitari Sant Joan de Deu, Universitat de Barcelona, Sant Boi de Llobregat, Spain Fundació Sant Joan de Déu, Esplugues de Llobregat, Spain Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain
    PLoS ONE 9:e84794. 2014
    ..The aim of our study was to examine multimorbidity patterns, the relationship between physical and mental conditions and the distribution of multimorbidity in the Spanish adult population...
  52. doi Association of childhood adversities with the first onset of mental disorders in Spain: results from the ESEMeD project
    Jaime Perales
    Parc Sanitari Sant Joan de Deu, Fundació Sant Joan de Déu, Dr Antoni Pujades, 42, 08830, Sant Boi de Llobregat, Barcelona, Spain
    Soc Psychiatry Psychiatr Epidemiol 48:371-84. 2013
    ..The present paper studies the prevalence of a wide variety of CAs, as well as their relationship to the onset of mental disorders in a representative sample of a Spanish population...
  53. ncbi Neurocognitive performance and negative symptoms: are they equal in explaining disability in schizophrenia outpatients?
    Victoria Villalta-Gil
    Research and Development Unit, Sant Joan de Déu Serveis de Salut Mental, Fundació Sant Joan de Déu, C Dr Antoni Pujadas 42, 08830, St Boi de Llobregat, Barcelona, Spain
    Schizophr Res 87:246-53. 2006
    ..The aim of this study is to assess if cognitive variables and symptom dimensions can predict disability in a sample of outpatients with schizophrenia...
  54. ncbi The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophrenia
    Josep Maria Haro
    Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
    CNS Drugs 20:293-301. 2006
    ..This important information is likely to impact on the future use of antipsychotics and will assist clinicians in refining the use of these drugs and improving the outcome of patients to whom they are prescribed...
  55. ncbi The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment
    J M Haro
    Research and Development Unit, Sant Joan de Deu SSM, Sant Boi, Barcelona, Spain
    Acta Psychiatr Scand 107:222-32. 2003
    ..The role of observational studies in the assessment of the effectiveness of antipsychotic agents is reviewed, and the rationale, design and recruitment issues surrounding the SOHO study are presented...
  56. ncbi The European Study of the Epidemiology of Mental Disorders (ESEMeD/MHEDEA 2000) project: rationale and methods
    J Alonso
    Health Services Research Unit, Institut Municipal d Investigacio Medica IMIM IMAS, Barcelona, Spain
    Int J Methods Psychiatr Res 11:55-67. 2002
    ..The analysis of these differences should facilitate the monitoring of ongoing mental health reform initiatives in Europe and provide new research hypotheses...
  57. ncbi Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study
    J M Haro
    Sant Joan de Déu Serveis de Salut Mental, Sant Boi, Barcelona, Spain
    Acta Psychiatr Scand 111:220-31. 2005
    ..To present the 6-month outcomes associated with antipsychotic treatment of patients participating in the Schizophrenia Outpatient Health Outcomes (SOHO) study...
  58. ncbi Utilisation of mental health services and costs of patients with schizophrenia in three areas of Spain
    J M Haro
    Centro de Investigacíon en Minusvalías, Universidad de Cadiz, Spain
    Br J Psychiatry 173:334-40. 1998
    ....
  59. ncbi Health-related quality of life in the Cambridge City over-75s Cohort (CC75C): development of a dementia-specific scale and descriptive analyses
    Jaime Perales
    Parc Sanitari Sant Joan de Deu, Sant Boi de Llobregat, Barcelona, Spain
    BMC Geriatr 14:18. 2014
    ..The aim of this study is to explore the distribution of HRQL by functional and socio-demographic variables in a population-based setting...
  60. doi Comorbidity of major depressive episode and chronic physical conditions in Spain, a country with low prevalence of depression
    Andrea Gabilondo
    Public Mental Health Network of Gipuzkoa, Osakidetza, Donostia, Spain
    Gen Hosp Psychiatry 34:510-7. 2012
    ..The objectives were to describe the comorbidity between 12-month major depressive episode (MDE) and chronic physical condition (CPC) in Spain, a Latin country with relatively low prevalence of depression...
  61. ncbi Met and unmet needs of schizophrenia patients in a Spanish sample
    S Ochoa
    Unitat de Formació i Investigació, Sant Joan de Déu SMM, Sant Boi de Llobregat, Barcelona, Spain
    Schizophr Bull 29:201-10. 2003
    ..In a multiple regression model, needs were weakly associated with the clinical variables and quality of life. Needs assessment is complementary to clinical evaluation in schizophrenia...
  62. ncbi Predictability of rehospitalization for schizophrenia
    J M Haro
    Department of Psychiatry, , Barcelona, Spain
    Eur Arch Psychiatry Clin Neurosci 244:241-6. 1994
    ..The results also show that the risk of rehospitalization depends on the previous tenures in the community...
  63. doi Effects of common mental disorders and physical conditions on role functioning in Spain
    Gabriela Barbaglia
    Health Services Research Unit, IMIM Institut Hospital del Mar d Investigacions Mèdiques, Barcelona, Spain Pompeu Fabra University UPF, Barcelona, Spain CIBER de Epidemiología y Salud Pública CIBERESP, Spain
    Gac Sanit 27:480-6. 2013
    ..To examine the effects of common mental disorders and physical conditions on role functioning in Spain...
  64. doi Association between annual earnings and mental disorders in Spain: individual and societal-level estimates
    Gabriela Barbaglia
    Health Services Research Unit, IMIM, Institut de Recerca Hospital del Mar, 88, Carrer del Doctor Aiguader, E 80003 Barcelona, Spain
    Soc Psychiatry Psychiatr Epidemiol 47:1717-25. 2012
    ..Indirect costs of mental disorders are considerable and include loss of work productivity. We aimed to study the association between personal annual earnings and common mental disorders in Spain...
  65. doi Comparison of treatment discontinuation and hospitalization among nonadherent patients initiating depot or oral typical antipsychotic medications
    Diego Novick
    Eli Lilly and Company, Windlesham, UK
    Int Clin Psychopharmacol 27:275-82. 2012
    ..In the usual care of outpatients with schizophrenia, treatment continuation among nonadherent patients is longer for depot typicals compared with oral typicals and is accompanied by less hospitalization in the short term...
  66. doi Antipsychotic monotherapy and polypharmacy in the treatment of outpatients with schizophrenia in the European Schizophrenia Outpatient Health Outcomes Study
    Diego Novick
    Health Outcomes Research, Eli Lilly and Company, Windlesham, Surrey, United Kingdom
    J Nerv Ment Dis 200:637-43. 2012
    ..Olanzapine was found to have the highest monotherapy rate and the longest duration of maintained monotherapy, followed by risperidone, amisulpride, and quetiapine...
  67. pmc The transcription factor SP4 is reduced in postmortem cerebellum of bipolar disorder subjects: control by depolarization and lithium
    Raquel Pinacho
    Parc Sanitari Sant Joan de Deu, Fundació Sant Joan de Déu, Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Barcelona, Spain
    Bipolar Disord 13:474-85. 2011
    ..We hypothesized that SP4 levels may be altered in the brain of bipolar disorder (BD) subjects and regulated by neuronal activity and drug treatment...
  68. ncbi Gender differences in response to antidepressant treatment prescribed in primary care. Does menopause make a difference?
    Alejandra Pinto-Meza
    Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Spain
    J Affect Disord 93:53-60. 2006
    ....
  69. ncbi Needs and its relation to symptom dimensions in a sample of outpatients with schizophrenia
    S Ochoa
    Research and Development Unit, Sant Joan de Deu SSM, C Dr Pujades, 42, 08830 Sant Boi de Llobregat, Barcelona, Spain
    Schizophr Res 75:129-34. 2005
    ..To analyse the association between symptom dimensions in schizophrenia and number and type of met and unmet needs...
  70. ncbi Influence of gender on social outcome in schizophrenia
    J Usall
    Sant Joan de Deu, Serveis Salut Mental, Barcelona, Catalonia, Spain
    Acta Psychiatr Scand 106:337-42. 2002
    ..To study the relevance of gender on social functioning in schizophrenia...
  71. doi ROAMER: roadmap for mental health research in Europe
    Josep Maria Haro
    Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain Research and Development Unit, Parc Sanitari Sant Joan de Deu, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain Universitat de Barcelona, Barcelona, Spain
    Int J Methods Psychiatr Res 23:1-14. 2014
    ..The process is inclusive and participatory, incorporating a wide diversity of European expert researchers as well as the views of service users, carers, professionals and policy and funding institutions...
  72. ncbi Validation in Spanish population of the family objective and subjective burden interview (ECFOS-II) for relatives of patients with schizophrenia
    M Vilaplana
    Research and Development Unit, Fundación de Investigación, San Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
    Actas Esp Psiquiatr 35:372-81. 2007
    ..This paper aims to show the validity and reliability of the Spanish version of the Family Burden Interview Schedule (FBIS) designed to assess objective and subjective family burden for people with schizophrenia...
  73. pmc Association of perceived stigma and mood and anxiety disorders: results from the World Mental Health Surveys
    J Alonso
    Health Services Research Unit, Institut Municipal d Investigació Mèdica IMIM Hospital del Mar, Barcelona, Spain
    Acta Psychiatr Scand 118:305-14. 2008
    ..We assessed the prevalence of perceived stigma among persons with mental disorders and chronic physical conditions in an international study...
  74. ncbi [One year prevalence of mental disorders comorbidity and associated socio-demographic risk factors in the general population of Spain. Results of the ESEMeD-Spain study]
    J Autonell
    Sant Joan de Déu Serveis de Salut Mental, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona
    Actas Esp Psiquiatr 35:4-11. 2007
    ..Comorbidity among mental disorders in the general population is common, affecting more than the 50 % of individuals with a lifetime mental disorder. In Spain, there are no data describing it or its associated risk factors...
  75. ncbi [Epidemiology of mental disorders in Spain: methods and participation in the ESEMeD-Spain project]
    J M Haro
    San Juan de Dios SSm Sant Boi de Llobregat, Barcelona, Spain
    Actas Esp Psiquiatr 31:182-91. 2003
    ....
  76. ncbi Risk factors for suicidality in Europe: results from the ESEMED study
    M Bernal
    Sant Joan de Déu Serveis de Salut Mental, Fundació Sant Joan de Déu, Dr Antoni Pujades 42, 08830, Sant Boi de Llobregat, Spain
    J Affect Disord 101:27-34. 2007
    ..The aims of the present study were to investigate the prevalence and correlates of suicidal ideas and attempts in the general population of Europe...
  77. ncbi The social, psychopathological and consumer context of rate of symptom improvement in acute mania
    Jim Van Os
    Dept of Psychiatry and Neuropsychology, Maastricht University, European Graduate School of Neuroscience, PO Box 616, 6200, MD, Maastricht, The Netherlands
    Soc Psychiatry Psychiatr Epidemiol 42:631-8. 2007
    ..Knowledge of moderators of symptom improvement over time in acute mania improves predictability of individual patient outcomes. This study attempted to identify such moderators of the rate of symptom improvement...
  78. ncbi Clinical consequences of switching antipsychotic drugs in outpatients with schizophrenia: 36-month results from the European Schizophrenia Outpatient Health Outcomes study
    Diego Novick
    Eli Lilly and Company, Windlesham, Surrey, UK
    Int Clin Psychopharmacol 23:203-8. 2008
    ..Patients who switched to olanzapine experienced a higher weight gain. In conclusion, among patients switching antipsychotic medication, those who switched to olanzapine had better long-term outcomes...
  79. doi Stability and treatment outcome of distinct classes of mania
    Inge van Rossum
    Medical Department, Eli Lilly Nederland, Grootslag 1 5, Houten, The Netherlands
    Eur Psychiatry 23:360-7. 2008
    ..Differential treatment course and outcome after 12 weeks of treatment were examined for three distinct classes of patients with acute mania in bipolar disorder...
  80. doi Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD)
    Koen Demyttenaere
    Department of Psychiatry, University Hospital Gasthuisberg, Leuven, Belgium
    J Affect Disord 110:84-93. 2008
    ..To examine factors associated with the use of antidepressants (AD) and benzodiazepines (BZD) in 6 European countries...
  81. ncbi Sexual intercourse frequency in men presenting for treatment of erectile dysfunction: results from the pan-European erectile dysfunction observational study
    Alan Riley
    Lancashire School of Health and Postgraduate Medicine, University of Central Lancashire, Preston, United Kingdom
    J Sex Marital Ther 33:3-18. 2007
    ....
  82. pmc Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys
    Philip S Wang
    Division of Services and Intervention Research, National Institute of Mental Health, Rockville, MD, USA
    Lancet 370:841-50. 2007
    ..We describe mental health care in 17 countries participating in the WHO world mental health (WMH) survey initiative and examine unmet needs for treatment...
  83. ncbi Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study
    Diego Novick
    Eli Lilly and Company, Lilly Research Centre, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, GU20 6PH, UK
    Psychopharmacology (Berl) 191:1015-22. 2007
    ..Symptomatic remission is an achievable goal of treatment in patients with schizophrenia...
  84. ncbi Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Isabelle Gasquet
    INSERM U669, Maison des Adolescents, Hopital Cochin, AP HP, Paris, France
    Int Clin Psychopharmacol 20:199-205. 2005
    ..The results should be interpreted conservatively due to the observational study design...
  85. ncbi Methodological approach for assessing the cost-effectiveness of treatments using longitudinal observational data: the SOHO study
    Frank Windmeijer
    Department of Economics, University of Bristol, UK
    Int J Technol Assess Health Care 22:460-8. 2006
    ....
  86. ncbi Cost-utility analysis of treatment with olanzapine compared with other antipsychotic treatments in patients with schizophrenia in the pan-European SOHO study
    Martin Knapp
    Centre for the Economics of Mental Health, Institute of Psychiatry, London, UK
    Pharmacoeconomics 26:341-58. 2008
    ..To determine the cost utility of treating schizophrenic patients with olanzapine compared with other antipsychotics in a naturalistic outpatient setting...
  87. ncbi Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: results from the erectile dysfunction observational study (EDOS)
    Antonio Martin-Morales
    Hospital Carlos Haya, Servicio de Urologia, Malaga, Spain
    Eur Urol 51:541-50; discussion 550. 2007
    ..This observational study was conducted across Europe to assess health outcomes in men with erectile dysfunction (ED) who took tadalafil, sildenafil citrate (sildenafil), or vardenafil HCl (vardenafil) for 6 mo...
  88. ncbi Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes
    Lizheng Shi
    Department of Health Systems Management, Tulane University, New Orleans, LA, USA
    Curr Med Res Opin 22:961-6. 2006
    ..The objective of this study was to describe clinical and work functional outcomes associated with 6-month open-label olanzapine treatment for bipolar I disorder...
  89. ncbi Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: results from the European Schizophrenia Outpatients Health Outcomes (SOHO) study
    Diego Novick
    Eli Lilly and Company, Windlesham, Surrey, UK
    Prog Neuropsychopharmacol Biol Psychiatry 29:972-82. 2005
    ..The results should be interpreted conservatively due to the observational design of SOHO...
  90. ncbi [Prevalence and risk factors for suicide ideation, plans and attempts in the Spanish general population. Results from the ESEMeD study]
    Andrea Gabilondo
    Unidad de Investigación en Servicios Sanitarios, Institut Municipal d Investigacio Medica, Barcelona, Espana
    Med Clin (Barc) 129:494-500. 2007
    ..Suicide is a public health problem and it is increasing in Spain. The objective of this study is to analyze the prevalence and risk factors of suicide related outcomes (ideation, plan and attempt) using data from the ESEMeD-Spain project...
  91. ncbi Assessment of remission in schizophrenia with the CGI and CGI-SCH scales
    Josep Maria Haro
    Acta Psychiatr Scand 117:156. 2008
  92. ncbi Differences in lifetime use of services for mental health problems in six European countries
    Viviane Kovess-Masfety
    Mutuelle Générale de l Education Nationale MGEN Foundation for Public Health, EA 4069, University of Paris 5, Paris, France
    Psychiatr Serv 58:213-20. 2007
    ....
  93. pmc Mental disorders among persons with heart disease - results from World Mental Health surveys
    Johan Ormel
    Department of Psychiatry, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands
    Gen Hosp Psychiatry 29:325-34. 2007
    ..Consistency across emotional disorders and cultures would suggest that relatively universal mechanisms underlie the association...
  94. ncbi Mental disorders among persons with chronic back or neck pain: results from the World Mental Health Surveys
    Koen Demyttenaere
    Department of Neurosciences and Psychiatry, University Hospital Gasthuisberg, Herestraat 49, B 3000 Leuven, Belgium
    Pain 129:332-42. 2007
    ..The association of mental disorders with back/neck pain showed a consistent pattern across both developed and developing countries...
  95. ncbi Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys
    Josep Maria Haro
    Int J Methods Psychiatr Res 15:167-80. 2006
    ..The validity of the CIDI is likely to be under-estimated in these comparisons due to the fact that the reliability of the SCID diagnoses, which is presumably less than perfect, sets a ceiling on maximum CIDI-SCID concordance...
  96. ncbi Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys
    Koen Demyttenaere
    JAMA 291:2581-90. 2004
    ..Little is known about the extent or severity of untreated mental disorders, especially in less-developed countries...